发明申请
US20050101623A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
审中-公开
β-咔啉化合物及其类似物作为丝裂原活化蛋白激酶活化蛋白激酶-2抑制剂
- 专利标题： Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
- 专利标题（中）： β-咔啉化合物及其类似物作为丝裂原活化蛋白激酶活化蛋白激酶-2抑制剂
-
申请号： US10894594申请日： 2004-07-20
-
公开(公告)号： US20050101623A1公开(公告)日： 2005-05-12
- 发明人: Marvin Meyers , David Anderson , Shridhar Hegde , John Trujillo , David Reitz , Matthew Mahoney , William Vernier , Ingrid Buchler , Kun Wu
- 申请人： Marvin Meyers , David Anderson , Shridhar Hegde , John Trujillo , David Reitz , Matthew Mahoney , William Vernier , Ingrid Buchler , Kun Wu
- 申请人地址： US MO Chesterfield
- 专利权人： Pharmacia Corporation
- 当前专利权人： Pharmacia Corporation
- 当前专利权人地址： US MO Chesterfield
- 主分类号： A61K
- IPC分类号： A61K20060101 ; A61K31/40 ; A61K31/403 ; A61K31/407 ; A61K31/4745 ; A61K31/55 ; C07D209/82 ; C07D209/94 ; C07D471/02 ; C07D471/14
摘要：
The present invention provides novel bridged beta-carboline compounds that are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 and analogues thereof and pharmaceutical compositions and kits that include these compounds.
信息查询
